IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
The Supreme Court has handed down momentous decisions over the past two decades on a variety of hot-button issues. But some of the most consequential rulings — for our physical
When the world experienced a hard season of flu and respiratory illness in 2021 and 2022, European firms launched convenient, three-in-one tests for the flu, COVID, and RSV. Americans were left wondering why they weren't coming out of U.S. labs.
Howard Dean, former governor of Vermont and Democratic National Committee chair, says the US needs to expand diagnostic innovation and patent eligibility to provide basic illness tests for patients and curb China’s lead.
The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure.